LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.81 | 84.90 | 1720 | 1769 | 0.9720 | 0.9871 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.51 | 84.90 | 24 | 1923 | 0.0125 | -0.2447 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.51 | 84.90 | 1774 | 1923 | 0.9224 | 0.9645 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.51 | 84.90 | 1750 | 1923 | 0.9100 | 0.9585 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 26.51 | 84.90 | 1790 | 1923 | 0.9308 | 0.9684 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.21 | 84.90 | 32 | 2091 | 0.0153 | -0.1903 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.21 | 84.90 | 1912 | 2091 | 0.9142 | 0.9616 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.21 | 84.90 | 1783 | 2091 | 0.8525 | 0.9321 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.21 | 84.90 | 1815 | 2091 | 0.8678 | 0.9396 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.92 | 84.90 | 53 | 2237 | 0.0237 | -0.0950 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.92 | 84.90 | 2027 | 2237 | 0.9058 | 0.9585 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.92 | 84.90 | 1902 | 2237 | 0.8500 | 0.9323 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.92 | 84.90 | 1928 | 2237 | 0.8616 | 0.9379 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.62 | 84.90 | 74 | 2449 | 0.0302 | -0.0279 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.62 | 84.90 | 2130 | 2449 | 0.8695 | 0.9432 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.62 | 84.90 | 2022 | 2449 | 0.8254 | 0.9224 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.62 | 84.90 | 2044 | 2449 | 0.8344 | 0.9267 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.32 | 84.90 | 89 | 2722 | 0.0327 | 0.0095 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.32 | 84.90 | 2266 | 2722 | 0.8324 | 0.9280 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.32 | 84.90 | 2128 | 2722 | 0.7817 | 0.9039 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.32 | 84.90 | 2145 | 2722 | 0.7879 | 0.9069 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 35.03 | 84.90 | 129 | 2991 | 0.0431 | 0.0848 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 35.03 | 84.90 | 2386 | 2991 | 0.7976 | 0.9139 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 35.03 | 84.90 | 2164 | 2991 | 0.7234 | 0.8779 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 35.03 | 84.90 | 2179 | 2991 | 0.7284 | 0.8804 | MN20160318_Q02 | L04 |